RTI Surgical (RTIX) Posts Q2 Loss of 5c/Share; Will Conduct Strategic Business Review
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
RTI Surgical® Announces 2016 Second Quarter Results
July 27, 2016 7:30 AM EDTCompany Will Hold Conference Call at 8:30 a.m. ET
ALACHUA, Fla.--(BUSINESS WIRE)-- RTI Surgical Inc. (RTI) (Nasdaq: RTIX), a global surgical implant company, reported operating results for the second quarter of 2016 as follows:
Quarterly Highlights:
Achieved worldwide revenues of $67.6 million, exceeding company revenue guidance of $66 million to $67 million. Achieved worldwide direct revenues of $39.6 million, a 16 percent increase over the... MoreRTI Surgical® Continues to Advance Science Behind Allograft Implantation
July 25, 2016 4:35 PM EDTPeer-Reviewed, Pre-Clinical Study Published in Journal of Tissue Engineering
ALACHUA, Fla.--(BUSINESS WIRE)-- RTI Surgical, Inc. (RTI) (Nasdaq: RTIX), a leading global surgical implant company, announced that a peer-reviewed, pre-clinical study titled Multipotent adult progenitor cells on an allograft scaffold facilitate the bone repair process has been published in the latest edition of the Journal of Tissue Engineering.
The pre-clinical study, conducted by Amanda LoGuidice, PhD., used similar materials to the proprietary, patented MAPC®-based technology used in RTI Surgicals map3® Cellular Allogeneic Bone Grafts. The study is the... More
